The Bio Report

Managing Pain without Addiction

09.20.2023 - By Levine Media GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Ketan Mehta, founder and CEO of Tris Pharma, discusses its experimental opiod Cebranopadol, how it modulates the addictive potential by targeting two receptors at once, and its potential to address the opioid crisis.

More episodes from The Bio Report